From: Association of serum glycine levels with metabolic syndrome in an elderly Chinese population
<65y | ≥65y | |||||||
---|---|---|---|---|---|---|---|---|
T1 | T2 | T3 | P trend a | T1 | T2 | T3 | P trend a | |
MetS | ||||||||
Model 1 b | 1.0 | 0.71 (0.25–2.04) | 1.08 (0.39–3.04) | 0.872 | 1.0 | 0.59 (0.36–0.98) | 0.34 (0.20–0.58) | < 0.001 |
Model 2 c | 1.0 | 0.72 (0.25–2.07) | 1.09 (0.39–3.05) | 0.868 | 1.0 | 0.55 (0.3–0.92) | 0.29 (0.17–0.51) | < 0.001 |
Model 3 d | 1.0 | 0.62 (0.18–2.12) | 0.96 (0.30–3.01) | 0.973 | 1.0 | 0.60 (0.35–1.05) | 0.31 (0.17–0.56) | < 0.001 |
Central obesity | ||||||||
Model 1 b | 1.0 | 0.59 (0.20–1.71) | 0.90 (0.30–2.69) | 0.862 | 1.0 | 0.58 (0.35–0.98) | 0.48 (0.29–0.81) | 0.006 |
Model 2 c | 1.0 | 0.62 (0.21–1.82) | 0.91 (0.30–2.76) | 0.879 | 1.0 | 0.52 (0.30–0.89) | 0.38 (0.22–0.66) | 0.001 |
Model 3 d | 1.0 | 0.49 (0.15–1.66) | 0.73 (0.22–2.43) | 0.624 | 1.0 | 0.61 (0.35–1.09) | 0.41 (0.23–0.73) | 0.003 |
Hypertriglyceridemia | ||||||||
Model 1 b | 1.0 | 0.51 (0.14–1.77) | 0.91 (0.29–2.87) | 0.888 | 1.0 | 0.67 (0.40–1.14) | 0.41 (0.23–0.73) | 0.002 |
Model 2 c | 1.0 | 0.53 (0.15–1.87) | 0.92 (0.29–2.29) | 0.891 | 1.0 | 0.61 (0.35–1.05) | 0.34 (0.19–0.62) | < 0.001 |
Model 3 d | 1.0 | 0.52 (0.14–1.95) | 0.98 (0.30–3.18) | 0.974 | 1.0 | 0.66 (0.37–1.17) | 0.38 (0.20–0.70) | 0.002 |
Hypo-HDL-cholesterolemia | ||||||||
Model 1 b | 1.0 | 1.67 (0.48–5.86) | 3.03 (0.90–10.11) | 0.066 | 1.0 | 0.65 (0.37–1.14) | 0.53 (0.29–0.95) | 0.032 |
Model 2 c | 1.0 | 1.87 (0.51–6.82) | 3.28 (0.95–11.40) | 0.059 | 1.0 | 0.60 (0.34–1.07) | 0.46 (0.25–0.85) | 0.012 |
Model 3 d | 1.0 | 2.36 (0.54–10.25) | 3.98 (0.95–16.60) | 0.058 | 1.0 | 0.63 (0.34–1.17) | 0.51 (0.27–0.97) | 0.039 |
Hypertension | ||||||||
Model 1 b | 1.0 | 1.10 (0.36–3.32) | 1.29 (0.42–3.99) | 0.654 | 1.0 | 1.01 (0.57–1.81) | 0.79 (0.45–1.39) | 0.405 |
Model 2 c | 1.0 | 1.13 (0.37–3.42) | 1.30 (0.42–4.01) | 0.650 | 1.0 | 1.02 (0.57–1.83) | 0.79 (0.45–1.41) | 0.425 |
Model 3 d | 1.0 | 1.04 (0.31–3.54) | 1.19 (0.35–4.02) | 0.784 | 1.0 | 1.16 (0.62–2.15) | 0.78 (0.43–1.41) | 0.393 |
Impaired fasting glucose | ||||||||
Model 1 b | 1.0 | 1.61 (0.56–4.64) | 1.06 (0.36–3.14) | 0.936 | 1.0 | 0.87 (0.53–1.42) | 0.61 (0.37–1.00) | 0.052 |
Model 2 c | 1.0 | 1.61 (0.56–4.66) | 1.06 (0.36–3.15) | 0.936 | 1.0 | 0.91 (0.56–1.50) | 0.67 (0.40–1.10) | 0.114 |
Model 3 d | 1.0 | 1.85 (0.58–5.86) | 1.03 (0.33–3.21) | 0.992 | 1.0 | 0.92 (0.54–1.56) | 0.70 (0.41–1.19) | 0.182 |